Ocugen, Inc. — Investor Relations & Filings
Ocugen, Inc. is a clinical-stage biotechnology company focused on discovering, developing, and commercializing novel gene therapies, cell therapies, and vaccines. The company's primary mission is to develop treatments for blindness diseases, leveraging its first-in-class modifier gene therapy platform. This platform represents a potential paradigm shift in treating inherited retinal diseases by aiming to address multiple genetic mutations with a single product. In addition to its focus on ocular health, Ocugen is also advancing a pipeline that includes vaccines for infectious diseases. The company is dedicated to addressing significant unmet medical needs and providing innovative therapeutic options for patients with debilitating conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-14 | English | |
| FORM 8-K | 2026-05-14 | English | |
| 8-K - Ocugen, Inc. (0001372299) (Filer) | 2026-05-05 | English | |
| 8-K - Ocugen, Inc. (0001372299) (Filer) | 2026-05-04 | English | |
| ARS - Ocugen, Inc. (0001372299) (Filer) | 2026-04-28 | English | |
| SCHEDULE 13G/A - Ocugen, Inc. (0001372299) (Subject) | 2026-03-27 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46257527 | FORM 8-K | 2026-05-14 | English | ||
| 46289439 | FORM 8-K | 2026-05-14 | English | ||
| 41428961 | 8-K - Ocugen, Inc. (0001372299) (Filer) | 2026-05-05 | English | ||
| 41043585 | 8-K - Ocugen, Inc. (0001372299) (Filer) | 2026-05-04 | English | ||
| 37961514 | ARS - Ocugen, Inc. (0001372299) (Filer) | 2026-04-28 | English | ||
| 33062206 | SCHEDULE 13G/A - Ocugen, Inc. (0001372299) (Subject) | 2026-03-27 | English | ||
| 33033584 | 8-K - Ocugen, Inc. (0001372299) (Filer) | 2026-03-24 | English | ||
| 32998803 | 8-K - Ocugen, Inc. (0001372299) (Filer) | 2026-03-20 | English | ||
| 32890785 | 10-K - OCUGEN, INC. (0001372299) (Filer) | 2026-03-04 | English | ||
| 32890779 | 8-K - OCUGEN, INC. (0001372299) (Filer) | 2026-03-04 | English | ||
| 32890780 | 8-K - OCUGEN, INC. (0001372299) (Filer) | 2026-03-04 | English | ||
| 29170586 | 8-K Filing | 2026-02-09 | English | ||
| 29170562 | SCHEDULE 13G Filing | 2026-01-30 | English | ||
| 29170569 | 8-K Filing | 2026-01-23 | English | ||
| 29170585 | 8-K Filing | 2026-01-21 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adlai Nortye Ltd.
A clinical-stage biopharma firm developing cancer immunothe…
|
ANL | KY | Manufacturing |
|
ADLINE CHEM LAB LIMITED
Produces APIs, chemical intermediates, and specialty chemic…
|
524604 | IN | Manufacturing |
|
ADMA BIOLOGICS, INC.
Biopharmaceutical company that develops and manufactures pl…
|
ADMA | US | Manufacturing |
|
Advectus Life Sciences Inc.
Advances drug delivery systems using proprietary nanopartic…
|
AVXSF | CA | Manufacturing |
|
Adverum Biotechnologies, Inc.
A clinical-stage company developing gene therapies for ocul…
|
ADVM | US | Manufacturing |
|
Advicenne
A specialty pharmaceutical company developing treatments fo…
|
ALDVI | FR | Manufacturing |
|
AegirBio AB
A diagnostics company specializing in therapeutic drug moni…
|
AEGIR | SE | Manufacturing |
|
Aelis Farma
Biopharmaceutical company developing CB1 receptor inhibitor…
|
AELIS | FR | Manufacturing |
|
AEON Biopharma, Inc.
Clinical-stage company developing therapeutic applications …
|
AEON | US | Manufacturing |
|
Aequus Pharmaceuticals Inc.
Developing and commercializing specialty pharmaceutical pro…
|
AQS | CA | Manufacturing |
Ocugen, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32915/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32915 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32915 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32915 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32915}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Ocugen, Inc. (id: 32915)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.